Skip to main content

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.  

A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com 

Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.92
-2.72 (-1.29%)
AAPL  272.95
-1.28 (-0.47%)
AMD  213.84
+0.00 (0.00%)
BAC  52.30
+0.61 (1.18%)
GOOG  307.15
-5.88 (-1.88%)
META  657.01
+3.32 (0.51%)
MSFT  389.00
+0.00 (0.00%)
NVDA  184.89
-10.67 (-5.46%)
ORCL  150.31
+2.42 (1.64%)
TSLA  408.58
-8.82 (-2.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.